» Articles » PMID: 31980545

Prenatal Repair of Myelomeningocele and School-age Functional Outcomes

Abstract

Background And Objectives: The Management of Myelomeningocele Study (MOMS), a randomized trial of prenatal versus postnatal repair for myelomeningocele, found that prenatal surgery resulted in reduced hindbrain herniation and need for shunt diversion at 12 months of age and better motor function at 30 months. In this study, we compared adaptive behavior and other outcomes at school age (5.9-10.3 years) between prenatal versus postnatal surgery groups.

Methods: Follow-up cohort study of 161 children enrolled in MOMS. Assessments included neuropsychological and physical evaluations. Children were evaluated at a MOMS center or at a home visit by trained blinded examiners.

Results: The Vineland composite score was not different between surgery groups (89.0 ± 9.6 in the prenatal group versus 87.5 ± 12.0 in the postnatal group; = .35). Children in the prenatal group walked without orthotics or assistive devices more often (29% vs 11%; = .06), had higher mean percentage scores on the Functional Rehabilitation Evaluation of Sensori-Neurologic Outcomes (92 ± 9 vs 85 ± 18; < .001), lower rates of hindbrain herniation (60% vs 87%; < .001), had fewer shunts placed for hydrocephalus (49% vs 85%; < .001) and, among those with shunts, fewer shunt revisions (47% vs 70%; = .02) than those in the postnatal group. Parents of children repaired prenatally reported higher mean quality of life scores (0.15 ± 0.67 vs 0.11 ± 0.73; = .008) and lower mean family impact scores (32.5 ± 7.8 vs 37.0 ± 8.9; = .002).

Conclusions: There was no significant difference between surgery groups in overall adaptive behavior. Long-term benefits of prenatal surgery included improved mobility and independent functioning and fewer surgeries for shunt placement and revision, with no strong evidence of improved cognitive functioning.

Citing Articles

Implementation of laparotomy-assisted fetoscopic spina bifida repair in two centers in Latin America: rationale for this approach in this region.

Miranda J, Parra-Saavedra M, Contreras-Lopez W, Abello C, Parra G, Hernandez J AJOG Glob Rep. 2025; 5(1):100442.

PMID: 40027474 PMC: 11869015. DOI: 10.1016/j.xagr.2025.100442.


Prenatal Spina Bifida Repair: A Survey of Current Practice in the United States.

Garg S, Shah K, Lentskevich M, Yau A, Gosain A Plast Reconstr Surg Glob Open. 2024; 12(12):e6377.

PMID: 39703379 PMC: 11658745. DOI: 10.1097/GOX.0000000000006377.


Meet the Latina scientists advancing health and policy.

Rodrigues M Nature. 2024; 636(8042):S25-S27.

PMID: 39663486 DOI: 10.1038/d41586-024-03998-8.


Safety and efficacy of human umbilical cord-derived mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Athiel Y, Cariot L, Jouannic J, Maillet C, Mauffre V, Adam C Stem Cell Res Ther. 2024; 15(1):444.

PMID: 39568021 PMC: 11580231. DOI: 10.1186/s13287-024-03991-y.


The impact of a biocellulose-based repair of fetal open spina bifida on the need to untether the cord: is it time to unify techniques for prenatal repair?.

Lapa D, Callado G, Catissi G, Trigo L, Faig-Leite F, Sevilla A Einstein (Sao Paulo). 2024; 22:eAO0557.

PMID: 38695415 PMC: 11081024. DOI: 10.31744/einstein_journal/2024AO0557.


References
1.
Lachin J . Worst-rank score analysis with informatively missing observations in clinical trials. Control Clin Trials. 1999; 20(5):408-22. DOI: 10.1016/s0197-2456(99)00022-7. View

2.
Meuli M, Meuli-Simmen C, Hutchins G, Yingling C, Hoffman K, Harrison M . In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med. 1995; 1(4):342-7. DOI: 10.1038/nm0495-342. View

3.
Bruner J, Tulipan N, Richards W . Endoscopic coverage of fetal open myelomeningocele in utero. Am J Obstet Gynecol. 1997; 176(1 Pt 1):256-7. DOI: 10.1016/s0002-9378(97)80050-6. View

4.
Heffez D, Aryanpur J, Hutchins G, Freeman J . The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery. 1990; 26(6):987-92. View

5.
Farmer D, Thom E, Brock 3rd J, Burrows P, Johnson M, Howell L . The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol. 2017; 218(2):256.e1-256.e13. PMC: 7737375. DOI: 10.1016/j.ajog.2017.12.001. View